Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, medical device maker Vascular Solutions (NASDAQ:VASC) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at Vascular and see what CAPS investors are saying about the stock right now.

Vascular facts

Headquarters (founded)

Minneapolis, Minn. (1996)

Market Cap

$273.3 million

Industry

Health care supplies

Trailing-12-Month Revenue

$102.6 million

Management

Co-Founder/CEO Howard Root
CFO James Hennen

Return on Equity (average, past 3 years)

21.5%

Cash / Debt

$19.7 million / $0

Competitors

Abbott Labs
Medtronic
Johnson & Johnson

Sources: S&P Capital IQ and Motley Fool CAPS.

Just yesterday, CAPS member rknapton succinctly summed up the Vascular outperform case for our community: "Long. Medical instruments company. Nice steady growth. Buying back stock. Cash flow from operating activities growing. Earnings grew 17% on a 9% boost in revenues last quarter. Not bad here at 21x fwd estimates."

If you want market-thumping returns, you need to put together the best portfolio you can. Of course, despite a strong five-star rating, Vascular may not be your top choice.

Fool contributor Brian Pacampara has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson and Medtronic. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.